Botfet / Company detail

ACAD

universe

Acadia Pharmaceuticals Inc.

biotech

Moat score54out of 100

The numbers

Financial metrics

Quality gate and thesis context

Roic8.1%

Gross Margin91.7%

Revenue Cagr22.0%

Fcf Conversion26.9%

Fcf Yield3.1%

Interest Coverage0.0x

Market Cap B$3.4B

Pe8.8

Quality PassPass

Founder LedNo

Thesis AlignedYes

Moat Quant54

Why it may endure

Moat breakdown

Quant: 54 · Curator: 0

Market Share Stability6

Network Effects6

Pricing Power20

Regulatory Moat16

Switching Costs6

Conviction0/10

Leadership0/10

Vision0/10

← Back to the full screener